Nucleic Acid Isolation & Purification Market Report 2026

The nucleic acid isolation & purification market size has grown rapidly in recent years. It will grow from $6.6 billion in 2025 to $7.39 billion in 2026 at a compound annual growth rate (CAGR) of 12%. The growth in the historic period can be attributed to growth in molecular biology research, increasing diagnostic testing needs, development of genomic sequencing technologies, expansion of biotechnology industry, rising laboratory infrastructure growth.

The nucleic acid isolation & purification market size is expected to see rapid growth in the next few years. It will grow to $11.59 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing adoption of precision medicine, growing demand for genetic disease diagnosis, expansion of molecular diagnostics industry, rising investments in life science research, increasing requirement for high purity nucleic acid samples. Major trends in the forecast period include growing demand for high precision dna and rna purification, increasing adoption of rapid and automated extraction systems, rising use of molecular techniques in clinical and research settings, growing focus on high quality sample preparation solutions, increasing expansion of genetic testing and diagnostic applications.

The advancement of personalized medicine is expected to drive the growth of the nucleic acid isolation and purification market. Personalized medicine enables healthcare professionals to develop customized treatment strategies and make clinical decisions based on a genetic understanding of a patient’s condition. Nucleic acid isolation and purification support processes such as sequencing, cloning, and polymerase chain reaction, which help identify the underlying causes of diseases and enable the prescription of targeted precision therapies. For instance, in February 2024, according to data from the Personalized Medicine Coalition (PMC), a US-based nonprofit umbrella organization, the U.S. Food and Drug Administration approved 16 new personalized treatments for rare diseases in 2023, a notable increase from six approvals in 2022. Therefore, the growth of personalized medicine is propelling the nucleic acid isolation and purification market going forward.

Major companies operating in the nucleic acid isolation and purification market are focusing on the development of innovative products such as nucleic acid extraction kits. Nucleic acid extraction kits are designed to isolate and purify nucleic acids, including DNA and RNA, from various sample types such as blood, cells, and tissues. For example, in April 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a China-based manufacturer of in vitro diagnostic (IVD) products, introduced the Automated Nucleic Acid Extraction Workstation SAW-48 along with the Cell Nucleic Acid Extraction Kit. The SAW-48 is an in vitro diagnostic medical device that integrates sample loading, nucleic acid purification, and PCR preparation into a single system. It is designed for the extraction, enrichment, and purification of nucleic acids from multiple sample types, including cervical swabs and liquid-based cytology samples. When combined with the Cell Nucleic Acid Extraction Kit using the magnetic bead method, the system enables automated STD and HPV detection. This automated process reduces the risk of sample exposure and infection for laboratory personnel, while improving efficiency, shortening turnaround times, and enhancing result accuracy.

In January 2023, ALS Limited, an Australia-based testing laboratories company, acquired Invitek Molecular for an undisclosed amount. This acquisition reflects ALS Limited’s strategy to strengthen its testing capabilities and expand service offerings to deliver comprehensive solutions to its clients. Invitek Molecular is a Germany-based company specializing in customized nucleic acid purification solutions.

Major companies operating in the nucleic acid isolation & purification market report are Thermo Fisher Scientific Inc., Illumina Inc., F. Hoffmann-La Roche AG, Merck KGaA, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Takara Bio Inc., Promega Corporation, New England Biolabs, Norgen Biotek Corporation, AutoGen Inc., MagGenome, Zymo Research, LGC Limited, Biogenuix, PCR Biosystems Inc., Abcam plc., PerkinElmer Inc., GE Healthcare, QIAGEN, Danaher Corporation, Bioline, Biotechrabbit, BioWORLD, Epicentre, Hamilton, Omega Bio-tek, Sigma-Aldrich, FavorGen Biotech Corp, TIANGEN Biotech Co Ltd.

North America was the largest region in the nucleic acid isolation & purification market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid isolation & purification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nucleic acid isolation & purification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nucleic acid isolation and purification market includes revenues earned by entities from the extraction of DNA from animal and plant tissues, cultured mammalian cells, bacteria, and yeast cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.